Shopping Cart
- Remove All
- Your shopping cart is currently empty
PARP/EZH2-IN-1 is a novel dual inhibitor targeting PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for treating triple-negative breast cancer with wild-type BRCA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | PARP/EZH2-IN-1 is a novel dual inhibitor targeting PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for treating triple-negative breast cancer with wild-type BRCA. |
Targets&IC50 | PARP1:6.87 nM (IC50), EZH2:36.51 nM (IC50) |
Alias | PARP/EZH2-IN-1 |
Molecular Weight | 768.85 |
Formula | C43H41FN8O5 |
Cas No. | 2687273-52-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.